Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Mon Mar 31 23:17:22 GMT 2025
by
admin
on
Mon Mar 31 23:17:22 GMT 2025
|
| Protein Type | MONOCLONAL ANTIBODY CONJUGATE |
| Protein Sub Type | IGG1 |
| Sequence Origin | HUMAN |
| Sequence Type | COMPLETE |
| Record UNII |
3F0FR4W3H8
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
437914
Created by
admin on Mon Mar 31 23:17:22 GMT 2025 , Edited by admin on Mon Mar 31 23:17:22 GMT 2025
|
||
|
FDA ORPHAN DRUG |
438014
Created by
admin on Mon Mar 31 23:17:22 GMT 2025 , Edited by admin on Mon Mar 31 23:17:22 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
3F0FR4W3H8
Created by
admin on Mon Mar 31 23:17:22 GMT 2025 , Edited by admin on Mon Mar 31 23:17:22 GMT 2025
|
PRIMARY | |||
|
C101524
Created by
admin on Mon Mar 31 23:17:22 GMT 2025 , Edited by admin on Mon Mar 31 23:17:22 GMT 2025
|
PRIMARY | |||
|
1514889-12-3
Created by
admin on Mon Mar 31 23:17:22 GMT 2025 , Edited by admin on Mon Mar 31 23:17:22 GMT 2025
|
PRIMARY | |||
|
DB12413
Created by
admin on Mon Mar 31 23:17:22 GMT 2025 , Edited by admin on Mon Mar 31 23:17:22 GMT 2025
|
PRIMARY | |||
|
10033
Created by
admin on Mon Mar 31 23:17:22 GMT 2025 , Edited by admin on Mon Mar 31 23:17:22 GMT 2025
|
PRIMARY | |||
|
Indusatumab vedotin
Created by
admin on Mon Mar 31 23:17:22 GMT 2025 , Edited by admin on Mon Mar 31 23:17:22 GMT 2025
|
PRIMARY | |||
|
300000025303
Created by
admin on Mon Mar 31 23:17:22 GMT 2025 , Edited by admin on Mon Mar 31 23:17:22 GMT 2025
|
PRIMARY |
| From | To |
|---|---|
| 1_22 | 1_95 |
| 1_146 | 1_202 |
| 1_263 | 1_323 |
| 1_369 | 1_427 |
| 2_22 | 2_95 |
| 2_146 | 2_202 |
| 2_263 | 2_323 |
| 2_369 | 2_427 |
| 3_23 | 3_88 |
| 3_134 | 3_194 |
| 4_23 | 4_88 |
| 4_134 | 4_194 |
| 1_222 | 3_214 |
| 2_222 | 4_214 |
| 1_228 | 2_228 |
| 1_231 | 2_231 |
| Glycosylation Type | MAMMALIAN |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_299 |
| N | 2_299 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> CONJUGATE |
|
||
|
|
TARGET->CONJUGATED TOXIN |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
Structural Modifications
| Modification Type | Location Site | Location Type | Residue Modified | Extent | Fragment Name | Fragment Approval |
|---|---|---|---|---|---|---|
| AMINO ACID SUBSTITUTION | [1_222] [1_228] [1_231] [2_222] [2_228] [2_231] [3_214] [4_214] | C |
Amount:
|
Cysteinyl vedotin | 6603L01WUR |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Molecular Formula | CHEMICAL |
|
||||
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|